MAT1A and metabolic disease: These results showing that inhibition of Mat1a alleviates obesity and obesity-associated metabolic diseases are consistent with previous reports, which showed that disruption of other enzymes such as PEMT12 or NNMT15 involved in the methionine cycle leads to resistance to obesity.